Clinical Trial Update: Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Epinephrine Inhalation Aerosol USP in asthma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Epinephrine Inhalation Aerosol USP (epinephrine)

Snippet

Sponsor: Amphastar Pharmaceuticals, Inc. | Conditions: Asthma | Phase 3 | Status: COMPLETED